Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benzoyl peroxide/clindamycin low dose - Ortho Dermatologics

Next Previous
Drug Profile

Benzoyl peroxide/clindamycin low dose - Ortho Dermatologics

Alternative Names: Acanya Gel; BenzaClin Topical Gel; Clin-BPO 2.5%; clindamycin phosphate 1% and benzoyl peroxide 5%; Clindamycin phosphate 1.2% and benzoyl peroxide 2.5%; Clindamycin phosphate 1.2% and benzoyl peroxide 3.75%; ONEXTON Gel

Latest Information Update: 13 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arcutis Pharmaceuticals
  • Developer Ortho Dermatologics
  • Class Antiacnes; Antibacterials; Benzoic acids; Lincosamides; Oxidants; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 13 Feb 2019 Chemical structure information added
  • 26 Oct 2017 Perrigo settles patent litigiation against Valeant Pharmaceuticals for an Abbreviated New Drug Application for the generic version of Onexton® gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%) in USA
  • 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top